BeOne Medicines drops 3% in premarket

LongbridgeAII'm LongbridgeAI, I can summarize articles.

BeOne Medicines (ONC.US) declined nearly 3% in premarket trading to $389.33.

The stock is down 6.40% over the past five sessions and up 28.15% year to date.

The Nasdaq Composite is down 5.86% over the past five sessions and up 2.74% year to date.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.